Director, Global Health Economics Lead, Oncology Business Unit

Role Summary

Director, Global Health Economics Lead, Oncology Business Unit. Role within Takeda Oncology, reporting to the Head of Global Health Economics and US HEOR. Location: Boston, MA. The role leads value demonstration and evidence generation strategies for Takeda’s global oncology portfolio, partnering across R&D, Market Access, and LOC to accelerate patient access and optimize payer outcomes.

Responsibilities

• Drive and realize value demonstration strategies for Takeda‚Äôs global oncology portfolio, achieving rapid, broad patient access and delivering differentiated, evidence-based pricing through HTA and payer decision outcomes; lead cross-functional integration to accelerate market access and strengthen competitive advantage.
• Lead strategic development, execution, and optimization of global health economics plans, reimbursement strategy, and evidence communication; build tools and training to maximize adoption across regions.
• Mobilize and align cross-functional and cross-regional stakeholders (R&D, Market Access, LOC) to ensure seamless integration of evidence requirements and accelerate value realization for patients and payers.
• Co-lead the development of enterprise-level frameworks (e.g., Integrated Evidence Generation Plans) ensuring evidence and access strategies align with payer, HTA, and policy needs globally.
• Pioneer digital, data science, and AI-driven HEOR approaches, shaping Takeda‚Äôs market access strategy; influence enterprise-level decision-making and mentor emerging leaders.
• Advance Takeda‚Äôs global reputation by shaping thought leadership at international forums and consortia; build partnerships with HTA bodies, payers, academics, and clinicians to strengthen Takeda‚Äôs leadership in HE and value demonstration.
• Global Value Proposition: deliver differentiated global HE value propositions to drive optimal payer decisions and patient access; collaborate with Global Pricing, Value & Access to craft compelling value narratives.
• Identify high-value opportunities across the portfolio, including new indications, lifecycle extensions, and innovative contracting models.
• Evidence Generation: lead enterprise-wide vision for evidence generation to secure HTA, payer, and market access objectives; integrate payer and real-world data needs across programs; explore digital and AI approaches to evidence generation.
• Incorporate innovative endpoints and ensure HTA readiness (including JCA); translate complex analyses into actionable value stories for executives, payers, and policymakers.
• HE and Value & Access Tools: benchmark scientific rigor in HEOR studies; drive adoption of Value Platforms, Dossiers, and VBC toolkits; lead global rollouts and training; explore VBC options with Market Access and Pricing.
• Market Access: serve as enterprise expert and spokesperson for Takeda‚Äôs value proposition; monitor HTA/reimbursement trends to guide enterprise-level HE and access strategies.
• Communication/Publication: elevate Takeda‚Äôs visibility through HEOR communications and policy publications; translate analyses into compelling value narratives for key audiences.
• Foster Superior Collaboration: empower cross-functional and external networks; manage collaborations with HE thought leaders, vendors, and academic partners to maintain innovation and excellence in health economics.

Qualifications

• Required: Doctorate with 7+ years of experience, or Master‚Äôs with 9+ years, or Bachelor‚Äôs with 12+ years in healthcare with direct experience in global product value proposition development and interaction with payers/HTA bodies; strong patient-centered focus.
• Required: Robust understanding of the global payer environment and ex-US HTA landscapes (NICE, CADTH, PBAC, EU JCA) plus US Medicare (Part D), ICER trends; knowledge of reimbursement methodologies in Emerging Markets.
• Required: Strong knowledge and hands-on experience in health economics, HTA tools and methods, economic modelling, SLRs, ITCs, and statistical analyses; understanding of clinical/epidemiological information and outcomes research.
• Required: Leadership in a highly matrixed organization; strong analytical and communication skills; strategic thinking and problem-solving ability; influencing skills; ability to translate technical issues for non-technical audiences.
• Required: 5‚Äì10% domestic and/or international travel may be required.
• Preferred: Experience in Hematology and/or Oncology; deep knowledge of global HTA requirements (EU JCA) and HTA submissions; direct payer experience or Market Access experience; track record of peer-reviewed publications.

Education

• Education requirements aligned with qualifications above (doctorate/master/bachelor with years of experience in health economics, HTA, and payer interactions).